Castle Biosciences (CSTL) Amortizatization of Intangibles (2018 - 2026)

Castle Biosciences (CSTL) has 7 years of Amortizatization of Intangibles data on file, last reported at $454000.0 in Q1 2026.

• Quarterly Amortizatization of Intangibles fell 68.36% year-over-year to $454000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.2 million (down 49.57% YoY) and the FY2025 annual result came in at $4.2 million, down 36.89% from the prior year.
• Amortizatization of Intangibles fell to $454000.0 in Q1 2026 per CSTL's latest filing, from $708000.0 in the prior quarter.
• The five-year high for Amortizatization of Intangibles was $1.7 million in Q2 2024, with the low at $184000.0 in Q3 2022.
• Average Amortizatization of Intangibles over 5 years is $1.2 million, with a median of $1.2 million recorded in 2023.
• Year-over-year, Amortizatization of Intangibles surged 752.72% in 2023 and plunged 68.36% in 2026.
• Castle Biosciences' Amortizatization of Intangibles stood at $1.2 million in 2022, then jumped by 38.51% to $1.6 million in 2023, then dropped by 1.65% to $1.6 million in 2024, then tumbled by 56.11% to $708000.0 in 2025, then plunged by 35.88% to $454000.0 in 2026.
• Business Quant data shows CSTL's Amortizatization of Intangibles at $454000.0 in Q1 2026, $708000.0 in Q4 2025, and $905000.0 in Q3 2025.